Projektbeschreibung Neurofeedback in children with - Gepris

Transcription

Projektbeschreibung Neurofeedback in children with - Gepris
Neurofeedback in children with attention-deficit/hyperactivity disorder (ADHD) - a
controlled multicenter study of a non-pharmacological treatment approach
Antragsteller:
Professor Dr. Martin Holtmann
LWL-Universitätsklinik Bochum
Klinik der Ruhr-Universität Bochum
Klinik für Kinder- und Jugendpsychiatrie Psychotherapie - Psychosomatik
Heithofer Allee 64
59071 Hamm
Telefon: +49 2381 8931069
Telefax: +49 2381 8931169
E-Mail: martin.holtmann wkp-lwl.org
Fachliche Zuordnung
Klinische Neurowissenschaften II - Psychiatrie, Psychotherapie, Kinder- und
Jugendspychiatrie
Förderung von 2008 bis 2015
Förderung
Projektbeschreibung
Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood. At present,
pharmacotherapy like methylphenidate (e.g., Ritalin) is the treatment of choice for ADHD children. Among alternative
treatment approaches, Neurofeedback (EEG-Biofeedback) has emerged as a non-invasive treatment for children with
ADHD. Neurofeedback refers to a procedure that encourages the individual to exercise a certain amount of
self-control over his/her “brainwaves” as recorded by EEG. The rationale for using Neurofeedback as an intervention
in ADHD is the consistently reported neurophysiological deficit of cortical arousal in ADHD children. The aim of such
training is that the children learn how to bring their neurophysiological profile closer to that of non-ADHD children,
resulting in concomitant improvements in behaviour and cognition. The aim of this investigation is to examine the
efficacy of Neurofeedback in childhood ADHD in a prospective, randomized, controlled study, assessing its
effectiveness in comparison to an unspecific peripheral biofeedback treatment (electromyographic biofeedback) with
an identical setting. After a six-month delay, a follow-up examination will be conducted focusing on the long-term
effects.
DFG-Verfahren
Beteiligte Person:
Klinische Studien
Privatdozentin Dr. Ute Strehl
GEPRIS ist ein Projekt der Deutschen Forschungsgemeinschaft.
Sie erreichen GEPRIS unter http://www.dfg.de/gepris
(c) 1999 - 2017 Deutsche Forschungsgemeinschaft (http://www.dfg.de)